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the phagocytosis of LDL-opsonized GAS but anti-CD4 
antibody did not. Most of AM41-type GAS cells were 
killed in human blood, whereas only a few CM41-type cells 
were phagocytosed. Moreover, recombinant Scl1 (rScl1) 
derived from M41-type GAS could significantly decrease 
the opsonophagocytosis of AM41 but not CM41-type GAS 
because the rScl1 competitively blocked the binding of 
AM41-type GAS to LDL. Therefore, our findings suggest 
that LDL may be an opsonin to enhance CD36-dependent 
opsonic phagocytosis of GAS by monocyte.
Keywords Low-density lipoprotein · Group A 
Streptococcus · Opsonin · Phagocytosis · Monocyte
Abbreviations
GAS  Group A Streptococcus
AM41  M41-type GAS (ATCC 12373)
CM41  M41-type GAS (CMCC 32198)
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Introduction
Streptococcus pyogenes [group A Streptococcus (GAS)] 
can cause a number of suppurative infections, includ-
ing pharyngitis, impetigo/pyoderma, erysipelas, cellulitis, 
necrotizing fasciitis, toxic streptococcal syndrome, and 
scarlet fever, as well as nonsuppurative sequelae includ-
ing acute rheumatic fever and acute glomerulonephritis [1]. 
Based on the surface M protein, GAS is serologically sepa-
rated into over 200 M protein serotypes [2]. Streptococcal 
collagen-like protein 1 (Scl1) as one of the virulence fac-
tors of GAS is found on the cell surface of many M-type 
GAS [3]. Although Scl1s expressed by different M-type 
GAS share similar triple helix structure their amino acid 
Abstract Low-density lipoprotein (LDL) binds to group 
A Streptococcus (GAS) through Sc11 protein, and scaven-
ger receptor CD36 of monocyte mediates the endocytosis 
of native or modified LDL. Therefore, we hypothesized 
that LDL might be an opsonin enhancing the phagocytosis 
of LDL-bound GAS by monocyte. The results showed that 
LDL could significantly promote U937 cell to phagocytose 
M28 (ATCC BAA1064) and M41 (ATCC 12373, AM41)-
type GAS, and the phagocytosis rates were significantly 
increased, compared with LDL-free group. LDL, however, 
did not enhance the phagocytosis of M41 (CMCC 32198, 
CM41) or M6 (ATCC BAA946)-type GAS since these two 
strains did not bind to LDL. CD36 was the major scaven-
ger receptor mediating the uptake of LDL-bound GAS by 
monocyte U937 cells since anti-CD36 antibody abolished 
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sequence, especially in variable N-terminal region, varies 
significantly, so that Scl1s in M6 and M55-type GAS spe-
cifically bind to factor H [4], whereas Scl1s in M1, M12, 
M28 and M41 can interact with low-density lipoprotein 
(LDL) [5]. However, the significance of Scl1–LDL interac-
tion remains unknown.
HDL and LDL especially OxLDL were found to play 
anti-infectious role in protecting bacteria, viruses, or par-
asites infections in some studies, regardless of some con-
tradicting findings in other studies [6]. Scavenger receptor 
CD36 mediates the uptake of modified and native LDL 
and HDL by monocyte [7, 8]; however, OxLDL upregu-
lates CD36, whereas HDL downregulates CD36 via PPAR-
mediated pathways [7].
Therefore, we hypothesize that LDL may be an opsonin 
to interact with Scl1 to enhance the phagocytosis of LDL-
bound GAS by monocyte/macrophage.
Materials and methods
Bacterial cultures and fluorescence labeling
Three GAS strains M6 (ATCC BAA946), M28 (ATCC 
BAA1064), and M41 (ATCC 12373, AM41) were pur-
chased from American Tissue Culture Collection, and one 
strain M41 (CMCC 32198, CM41) was obtained from 
China Medical Culture Collection Center, respectively. 
Scl1 nucleotide sequence of CM41 is the same as that of 
AM41 (GenBank: EU915249.1). Some characteristics 
of four GAS strains are listed in Table 1. Scl1 expression 
and LDL binding capacity of the four GAS strains were 
assayed using RT-PCR and ELISA as described previously 
[5]. Based upon RT-PCR analysis, scl1 gene was expressed 
in AM41-type GAS but not in natural mutant CM41-type 
GAS (Figure S1A). Moreover, AM41-type GAS could bind 
to LDL but the interaction of CM41-type GAS with LDL 
was weak as demonstrated with ELISA (Figure S1B).
GAS cultures were grown on brain–heart infusion agar 
(BD Biosciences, USA) overnight and in Todd Hewitt 
broth (BD Biosciences, USA) supplemented with 0.2 % 
yeast extract (THY medium) at 37 °C in an atmosphere of 
5 % CO2. Logarithmic phase cultures harvested at the opti-
cal density (600 nm) of about 0.5–0.6 (OD600 nm) were 
used to prepare GAS. Colony counts were verified by plat-
ing on THY agar.
Prior to use in uptake assays, bacteria were labeled 
with fluorescein isothiocyanate (FITC, Sigma, USA) 
using method described previously [9]. Briefly, 10 ml of 
exponentially growing bacterial culture was pelleted and 
washed twice with sterile phosphate-buffered saline (PBS). 
The bacterial pellet was resuspended in 1 ml labeling solu-
tion (0.2 mg/ml FITC in PBS) and incubated in an atmos-
phere of 5 % CO2 at 37 °C for 30 min. The FITC-labeled 
bacteria were pelleted, washed once with cold PBS, and 
resuspended in RPMI 1640 medium (Gibco, USA) at a 
final concentration of ~109 cfu/ml.
Recombinant protein
Recombinant Scl1 (rScl1, C176) derived from M41-type 
GAS was produced in E. coli using the Strep-tag II expres-
sion and purification system (IBA-GmbH, Germany) as 
described previously [5, 10]. Briefly, six milliliter overnight 
pre-cultures of E. coli BL21 was inoculated into 300 ml of 
Luria–Bertani (LB) broth containing 100 μg/ml ampicillin 
and incubated at 37 °C under agitation (200 rpm). When 
OD600 reached 0.5–0.6, protein expression was induced by 
addition of anhydrotetracycline (0.2 μg/ml) and incubated 
at 30 °C under agitation (200 rpm) for another 3 h. Bacteria 
were harvested by centrifugation (10,000×g, 10 min, 4 °C), 
and the pellets were resuspended in a lysis buffer (100 mM 
Tris–HCl, 1 mM EDTA pH 8.0, 500 mM sucrose, 0.2 M 
PMSF) containing 10 μl lysozyme and 20 μl DNase. After 
incubated at room temperature for 30 min, the lysates were 
clarified by centrifugation (10,000×g, 10 min, 4 °C), and 
the recombinant polypeptides in supernatant were purified 
by affinity chromatography with Strep-Tactin Sepharose.
The protein content in the elution was determined by 
BCA™ Protein Assay Kit (Pierce Biotechnology, USA) 
using bovine serum albumin as a standard. Endotoxin in 
rScl1 preparations was removed by high-capacity endo-
toxin removal resin (Pierce Biotechnology, USA). The 
endotoxin content of rScl1 solution was <3 EU/ml deter-
mined by LAL Chromogenic Endotoxin Quantitation Kit 
(Pierce Biotechnology, USA).
Cell cultures
Most of the macrophage scavenger receptors, including 
class A, B, D, E, F and G, can mediate the internalization 
of LDL and/or oxLDL, whereas only class B receptors, 
including Type I, Type II and CD36, present on monocyte 
[7]. Therefore, human monocytic tumor cell line U937 
was used as a simple model to explore LDL-mediated 
opsonophagocytosis in the current study. Human monocytic 
U937 cells (ATCC CRL-1593.2, USA) were maintained 
Table 1  Characteristics of GAS strains
GAS strain Scl1 expression Binding to LDL
M41 (ATCC 12373, AM41) + +
M41 (CMCC 32198, CM41) − −
M28 (ATCC BAA1064) + + [5]
M6 (ATCC BAA946) + − [5]
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in RPMI1640 medium supplemented with 10 % heat-
inactivated fetal calf serum (Gibco, Australia), 292.28 µg/
ml l-glutamine and 100 units/ml penicillin/streptomycin 
(Gibco, USA). In the phagocytosis assays, cells were har-
vested and re-suspended in RPMI 1640 medium at a final 
concentration of 2.5 × 106/ml.
In vitro phagocytic assay
LDL‑mediated phagocytic assay
For opsonophagocytosis experiments, 100 µl of FITC-
labeled GAS (~109 cfu/ml) with or without LDL (10 µg/
ml final concentration of protein) (Biomedical Technolo-
gies, USA) was added into 1 ml of U937 cells (2.5 × 106/
ml) and incubated at 37 °C in an atmosphere of 5 % CO2. 
The final bacteria/monocytes ratio was about 15–50:1. The 
viable bacterium number in the mixture was determined 
by plating diluted samples onto THY agar plates after 
15-, 30-, 60-min incubation. To monitor bacterial fluo-
rescence intensity after the incubation, 200 µl of sample 
was pipetted into the 96-well microplate and measured at 
λ = 495 nm (excitation) and λ = 519 nm (emission) using 
a fluorescence plate reader (model Synergy HT, BioTek, 
USA).
To test the influence of LDL concentration on 
opsonophagocytosis, 10, 100 or 1000 µg/ml of LDL was 
used. To study the competitively inhibitory effect of rScl1 
on the LDL-mediated phagocytosis, assays were performed 
in essentially the same manner as described above except 
LDL was pre-incubated with an equal mole (20 nmol) of 
rScl1 for 1 min before adding to the cell culture.
To determine whether scavenger receptor CD36 was 
involved in the LDL-mediated phagocytosis of GAS by 
monocyte U937, monoclonal anti-CD36 antibody (SMO, 
Ancell, USA) was added to the cell suspension (10 µg/ml 
final concentration) to block the receptor before the phago-
cytosis assay. Irrelevant monoclonal anti-CD4 antibody 
(Ancell, USA) was used as the negative control (10 µg/ml 
final concentration).
Microscopy
In above LDL-mediated phagocytic assay, a 100 µl ali-
quot of U937 cells and FITC-labeled GAS mixture was 
taken out after 30-min incubation and placed on ice. DAPI 
(Sigma, USA) was added at a final concentration of 10 µg/
ml. After 10-min incubation, five milliliters of sample was 
plated onto slides, and FITC-GAS and DAPI-stained U937 
cell nuclei were imaged at 200× magnification on fluores-
cent microscope (model BX41, Olympus, Japan) equipped 
with MicroPublisher 3.3 RTV camera (Qimaging, Canada). 
After acquisition, two photographs of GAS (green) and 
nuclei (blue) in the same field of view were merged using 
Image Pro Plus 6.0 software.
Ex vivo phagocytic assay with human blood
Blood was obtained from healthy volunteers in accordance 
with Inner Mongolia Agricultural University institutional 
regulations. Whole blood was collected into 5-ml pyro-
gen-free vacuum tubes containing 3.2 % sodium citrate as 
anticoagulant. A 200 µl aliquot of blood was pre-incubated 
with 50 µl rScl1 or PBS at 37 °C under agitation (170 rpm) 
for 1 min. A 100 µl aliquot of AM41-type or CM41-type 
GAS (~103 cfu/ml) was added into the blood and agitated 
for 15 min at 37 °C. The cfu was determined by plating 
samples on THY agar plates.
Ethics statement
Experiments with human blood were approved by Aca-
demic Board and Science and Technology Department of 
the Inner Mongolia Agricultural University. The blood was 
taken from the volunteers with their authorization. All adult 
subjects signed written informed consent form, and chil-
dren were not invited to participate in this project.
Statistics
All treatments were performed in triplicate, and all experi-
ments were conducted for three times. All data are pre-
sented as the mean ± SD. Statistical significance was 
performed using the two-tailed paired Student’s t test. Sig-
nificance was determined at a level of [p < 0.001 (***)].
Results
LDL promotes the phagocytosis of GAS by human 
U937 monocyte
To test whether LDL can promote the phagocytosis of GAS 
by monocyte, colony counting, fluorescence intensity detec-
tion and microscopy observation were employed (Fig. 1). 
Based upon colony counts, LDL significantly enhanced the 
phagocytosis of M41-type GAS (ATCC 12373, AM41-type 
GAS). The phagocytosis rates were increased by 17, 58 and 
48 % at 15, 30 and 60 min, respectively, compared with 
LDL-free control (p < 0.01, Fig. 1a3). Similar results were 
obtained with fluorescence intensity detection. The uptake 
efficiency was increased by 17.6, 26.6 and 23.6 % at 15, 30 
and 60 min, respectively, compared with LDL-free control 
(Fig. 1a3). The phagocytosis rates determined by fluores-
cence intensity were usually lower than those calculated 
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with colony counts, because the intracellular FITC-labeled 
bacteria still fluoresced faintly. The opsonic phagocytosis 
was further demonstrated with microscopy (Fig. 1a1, LDL-
free control; Fig. 1a2, LDL-positive group). In contrast to 
AM41-type GAS, the addition of LDL did not increase the 
phagocytosis rates of M41-type GAS (CMCC 32198, CM-
41-type GAS) by U937 cells (Fig. 1b1–b3). The results also 
showed that LDL significantly promoted the ingestion of 
M28-type GAS (p < 0.001, Fig. 1c1–c3) but not M6-type 
GAS (Fig. 1d1–d3) since the former could bind to LDL 
but the latter could not. In overall, our data consistently 
demonstrated that LDL-opsonized GAS was phagocytosed 
more efficiently than GAS alone. To investigate whether 
internalized GAS was still alive 1 h after phagocytosis, 
U937 cells co-cultivated with GAS were lysed and plated 
onto THY agar plate [9, 11]. The colony-forming unit (cfu) 
of the total intracellular and extracellular live bacteria was 
not different from that of bacteria without the lysis of U937 
cells (data not shown). These results indicated that GAS 
was dead after ingestion by U937 cells. In addition, LDL 
alone promoted the growth of all tested GAS strains in the 
absence of U937 cells (data no shown) because LDL may 
act as a nutrient substance for GAS.
Mechanism underlying the LDL‑mediated phagocytosis 
of GAS
Inhibition of LDL‑mediated GAS phagocytosis 
by recombinant Scl1 (rScl1)
To test whether the binding of LDL to surface Scl1 of 
GAS was responsible for the opsonophagocytosis, rScl1 
was added to the mixture of GAS, LDL and U937 cells 
since rScl1 could competitively inhibit the interaction 
of LDL with GAS (Figure S2). The results showed that 
rScl1 abolished the LDL-mediated opsonophagocytosis 
of AM41-type GAS but did not have any impact on LDL-
free non-opsonic phagocytosis, which was consistent with 
the findings by fluorescence detection (Fig. 2a) and colony 
counting (Fig. 2b) after 30 min of co-cultivation of U937 
cells with FITC-labeled GAS.
Anti‑CD36 antibody abrogated the LDL‑dependent 
phagocytosis of GAS by U937 cells
To investigate which scavenger receptor of U937 cells 
was involved in LDL-mediated phagocytosis of GAS, 
Fig. 2  rScl1 inhibited LDL-
mediated phagocytosis of GAS 
by U937 cells. The phagocyto-
sis assay was carried out with 
similar procedure to Fig. 1 
except the addition of rScl1. a 
The phagocytosis rates were 
calculated based upon cfu after 
30-min incubation of U937 cells 
and GAS. b The phagocytosis 
rates were derived from fluo-
rescence intensity (fluor) after 
30-min co-culture of U937 cells 
and GAS
b
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Fig. 1  LDL-mediated phagocytosis of four GAS strains. After 
30-min incubation of U937 cells with FITC-labeled GAS DAPI 
was added and co-cultivated for 10 min; 5 ml of sample was plated 
onto slides, and GAS (green) and DAPI-stained U937 cell nuclei 
(blue) were imaged, respectively, at ×200 magnification on fluores-
cent microscope. a1, b1, c1 and d1 refer to control group, including 
AM41, CM41, M28 and M6-type GAS without LDL, whereas a2, 
b2, c2 and d2 stand for the treatments with LDL. The colony-forming 
units (cfu) of GAS in the mixture were determined by plating diluted 
samples onto THY agar plates after 15-, 30- and 60-min co-culture 
of FITC-GAS and U937 cells in the presence or absence of LDL. 
The phagocytosis rates were expressed as 100 % × (cfu of addi-
tion − cfu after co-culture)/cfu of addition. The red lines in a3, b3, c3 
and d3 refer to the phagocytosis rates calculated upon cfu. Bacterial 
fluorescence intensity was monitored at 15, 30 and 60 min of incuba-
tion, and 200 µl of sample was pipetted into the 96-well microplate 
and measured at λ = 495 nm (excitation) and λ = 519 nm (emis-
sion) using a fluorescence plate reader. The phagocytosis rates were 
expressed as 100 % × (initial absorbance value − absorbance value 
after co-culture)/initial absorbance value. The green lines in a3, b3, 
c3 and d3 refer to the phagocytosis rates calculated upon fluorescence 
(fluor)
◂
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monoclonal anti-CD36 antibody or an irrelevant anti-
CD4 antibody was added into the culture. In the pres-
ence of anti-CD36 antibody, extracellular bacterial 
cfu and fluorescence intensity of U937 cells, LDL and 
GAS culture were increased to the same level as the 
control (Fig. 3a, b). In contrast, the addition of anti-
CD4 antibody did not increase the extracellular bacte-
rial growth (Fig. 3a, b). Therefore, anti-CD36 antibody 
abrogated the LDL-dependent phagocytosis of AM41-
type GAS but did not decrease the LDL-independent 
phagocytosis. On the other hand, anti-CD4 antibody 
did not have any influence on either LDL-dependent 
or LDL-independent phagocytosis. These results indi-
cated that CD36 was responsible for the recognization 
of LDL–GAS complex, leading to the rapid uptake of 
GAS by monocyte.
Fig. 3  Role of anti-CD36 anti-
body in resistance to phagocyto-
sis of GAS by U937 cells. The 
phagocytosis assay was carried 
out with similar procedure 
to Fig. 1 except the addition 
of anti-CD36 antibody or 
anti-CD4 antibody. Percent of 
control = (viable GAS in other 
treatments/viable GAS of U937 
cells and GAS group) × 100 
was determined after 30-min 
co-culture and calculated from 
cfu (a) and fluorescence inten-
sity (b), respectively
a
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Fig. 4  Effect of LDL concen-
tration on the opsonic phagocy-
tosis of GAS by U937 cells. The 
phagocytosis assay was carried 
out with similar procedure to 
Fig. 1 except the variation of 
LDL concentration from 10 
to 1000 µg/ml. a The phago-
cytosis rates were calculated 
based upon cfu after 30-min 
incubation of U937 cells and 
GAS. b The phagocytosis rates 
were derived from fluorescence 
intensity (fluor) after 30-min co-
culture of U937 cells and GAS
a
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High concentration of LDL did not inhibit the 
LDL‑mediated phagocytosis
CD36 is a receptor of not only LDL [8] but also oxLDL [7]. 
Moreover, even freshly isolated LDL from human blood 
still contained some oxLDL [12]. In the above experiments, 
10 μg/ml of LDL which is less than physiological concen-
tration (about 1000 μg/ml) was used. Therefore, high con-
centration of LDL was tested; 100 or 1000 μg/ml of LDL 
was used to test whether LDL could competitively inhibit 
CD36 from recognizing LDL–GAS complex. The results 
showed that high concentration of LDL did not significantly 
decrease the phagocytosis rate even if the concentration of 
LDL in the culture was as high as 1000 μg/ml (Fig. 4a, b).
LDL enhanced the phagocytosis of GAS in human 
blood
To investigate whether LDL could promote the phagocytosis 
of GAS in human blood, we measured the viable number of 
AM41 and CM41-type GAS in whole blood with or without 
rScl1 after 15-min incubation. The phagocytic efficiency of 
AM41-type GAS was 69 % which was significantly higher 
than that of CM41-type GAS (16 %) (Fig. 5). The addition 
of rScl1 decreased the uptake of AM41-type GAS to 19 %, 
while phagocytosis rate for CM41-type GAS was reduced 
to 10 % (Fig. 5). Therefore, LDL also enhanced the killing 
of LDL-opsonized GAS in human blood.
Discussion
GAS infection is an increasing problem, with >500,000 
deaths per year [13]. Scl1–LDL interaction was found, 
but the significance of the interaction especially in the 
host immunity has not been uncovered. To the best of our 
knowledge, LDL was demonstrated for the first time to be 
an opsonin to enhance CD36-dependent opsonic phagocy-
tosis of GAS by monocyte and whole human blood in this 
study.
In fact, LDL presents anti-Klebsiella pneumoniae, K. 
pneumonia, Salmonella typhimurium, Listeria monocy‑
togenes, Mycobacterium tuberculosis and Vibrio vulnifi‑
cus capability of preventing these bacterium infections 
[6]. LDL but not HDL binds to prions from the brains of 
patients with sporadic Creutzfeldt–Jakob disease to pre-
vent the prion further invasion [14]; Pseudomonas aerugi‑
nosa was demonstrated to bind to oxLDL but not to LDL 
through protein PA0122 in a previous study [15] where 
the significance of the oxLDL–PA0122 interaction was 
not addressed. Our findings in this study demonstrated 
that the interaction of Sc11 and LDL played an important 
anti-infectious role. In fact, LDL may be an opsonin to 
enhance the phagocytosis of Yersinia pestis by monocyte 
due to the binding of LDL to Y. pestis [16]. However, pure 
pH6-Ag (similar to rScl1) can also competitively inhibit 
the binding of LDL to Y. pestis to abrogate LDL-mediated 
opsonophagocytosis of Y. pestis.
Oxidation of LDL may be a more important response of 
the host against infections; therefore, whether there exists 
an interaction of OxLDL with Sc11 and the implication 
of this interaction in the host innate immunity is worth 
pursuing.
We found for the first time that CD36 could be a much 
higher affinity receptor of the LDL opsonin receptor, 
because the results demonstrated that once LDL binds to 
GAS, LDL–GAS complex was quickly recognized by 
CD36 and phagocytosed by monocyte. The findings are 
not in line with the previous findings in other studies where 
scavenger receptors, including CD36, were previously 
thought to only mediate the non-opsonic phagocytosis of 
bacteria by monocyte/macrophage [17, 18].
Based upon our findings, monocyte or macrophage 
might ingest bacterium–LDL complex to protect against 
infections, which might result in the formation of foam 
cell, cholesterol-laden macrophage since LDL cholesterol 
is considered as a major factor in atherosclerosis develop-
ment [19]. So far, the validity of the hypothesis that infec-
tion contributes to atherosclerosis has not been definitively 
established although the evidence is becoming compelling 
[20–22]. Our findings might shed a new light on the cor-
relation between infections and atherosclerosis due to the 
double-edged sword property of LDL.
Severe invasive streptococcal infections are often asso-
ciated with systemic dissemination, which reflects the 
diverse abilities of GAS to avoid eradication by phago-
































Fig. 5  Phagocytosis of GAS in human blood. The 200 µl aliquot of 
fresh blood was pre-incubated with 50 µl rScl1 or PBS at 37 °C under 
agitation (170 rpm) for 1 min. A 100 µl aliquot of AM41-type or 
CM41-type GAS (~103 cfu/ml) was added into the blood and agitated 
at 37 °C for 15 min. The colony-forming unit (cfu) was determined 
by plating samples on THY agar plates. The phagocytosis rates were 
expressed as 100 % × (cfu of addition − cfu after co-culture)/cfu of 
addition
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bloodstream in most patients with invasive infection [23]. 
Polymorphonuclear neutrophils are the most important 
phagocytes in the blood; GAS, however, can avoid the kill-
ing by PMNs and survive within these cells [24]. Thus, 
LDL-mediated opsonophagocytosis of GAS by monocyte 
found in this study is particularly important for the rapid 
clearance of GAS by host since GAS inside the monocyte 
was killed within 1 h.
Our experiments were performed only in in vitro and 
ex vivo systems since GAS is a strictly human pathogen 
[25] and only a very few streptococcal strains can estab-
lish infection in mice. On the other hand, knockout of 
ApoB100 is lethal to animal. Therefore, a careful and 
profound strategy to further confirm the findings in this 
study in an in vivo system should be endeavored. Nev-
ertheless, our findings that LDL was identified to be an 
opsonin to enhance CD36 mediated phagocytosis of GAS 
by monocyte and whole human blood may provide clues 
for anti-GAS infection and atherosclerosis prevention 
strategies.
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